Method of preparing gas-filled polymer matrix microparticles useful for echographic imaging
View Patent ↗A method is provided to prepare gas-filled, porous microparticles having a polymer matrix interior which are useful as ultrasound echogenic contrast agents. An oil-in-water suspension is formed, both phases are frozen, then the aqueous and nonaqueous frozen phases are removed by sublimation. The resulting porous microparticles can receive a gas and be used as an ultrasound contrast agent.
1. A method of preparing gas-filled polymer matrix microparticles useful for echographic imaging, comprising the steps of:
a. emulsifying a polymer solution in an aqueous solution to form an oil-in-water emulsion-in which the polymer solution constitutes a discontinuous phase and the aqueous solution constitutes a continuous phase, wherein the polymer solution comprises a polymer dissolved in an organic solvent system that is substantially inuniscible with water;
b. freezing the oil-in-water emulsion;
c. removing the water and organic solvent system from the frozen emulsion by sublimation, thereby forming porous polymer matrix microparticles; and
d. introducing a gas into the pores of the porous matrix microparticles.
2. A method according to claim 1 , wherein said aqueous solution contains a biologically compatible amphiphilic material and the method further comprises the step subsequent to step a of diluting said emulsion into a second aqueous solution containing a chemical crosslinking agent, thereby forming an outer layer of crosslinked biologically amphiphilic material around said droplets.
3. A method according to claim 1 further comprising the step subsequent to step a of exchanging or partially exchanging said continuous phase by a second aqueous solution.
4. A method according to claim 1 wherein said polymer comprises a biodegradable synthetic polymer.
5. A method according to claim 4 wherein said biodegradable synthetic polymer is selected from the group consisting of polylactide, polycaprolactone, polyglycolide, polyhydroxybutyrate, polyhydroxyvalerate, and copolymers of any two or more thereof.
6. A method according to claim 5 wherein said biodegradable synthetic polymer is polylactide.
7. A method according to claim 2 wherein said biologically compatible amphiphilic material comprises a protein.
8. A method according to claim 7 wherein said protein is selected from the group consisting of serum albumin, gelatin, collagen, globulins, casein, and combinations of two or more thereof.
9. A method according to claim 8 wherein said protein is serum albumin.
10. A method according to claim 2 wherein said crosslinking agent comprises glutaraldehyde.
11. A method according to claim 1 wherein said water-immiscible solvent is selected from the group consisting of xylene, benzene, cyclohexane, cyclooctane, and combinations of two or more thereof.
12. A method according to claim 11 wherein said water-immiscible solvent is xylene.
13. A method according to claim 1 wherein said gas is selected from the group consisting of air, nitrogen, oxygen, argon, helium, carbon dioxide, xenon, a sulfur halide, and a halogenated hydrocarbon.
14. A method according to claim 13 wherein said gas is nitrogen.
15. A method of ultrasound imaging of organs or tissue of a patient, comprising the steps of:
a. reconstituting microparticles having a mean size range of about 1 to about 10 microns prepared according to any one of claims 1 through 14 in a physiologically acceptable aqueous liquid carrier to form a microparticle suspension,
b. injecting said suspension into said patient, and
c. echographically imaging said patient at an organ or tissue of interest.
16. The method according to claim 15 wherein said microparticles comprise a biodegradable synthetic polymer.